Press release content from NewMediaWire. The AP news staff was not involved in its creation.
FIBROGEN UPDATE
Faruqi & Faruqi LLPMay 1, 2021 GMT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In FibroGen To Contact Him Directly To Discuss Their Options
NEW YORK, NY - ( NewMediaWire ) - May 01, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FibroGen, Inc. (“FibroGen” or the “Company”) (NASDAQ:FGEN) and reminds investors of the June 11, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
DANIMER SCIENTIFIC SHAREHOLDER ALERT
Faruqi & Faruqi LLPMay 1, 2021 GMT
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Danimer Scientific To Contact Him Directly To Discuss Their Options
NEW YORK, NY - ( NewMediaWire ) - May 01, 2021 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Danimer Scientific Inc. (“Danimer Scientific” or the “Company”) (NYSE:DNMR).
If you suffered losses exceeding $50,000 investing in Danimer Scientific stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/DNMR.